Filing
Spy
Filing
Spy
Home
About
GILD
Gilead Sciences, Inc.
Biopharmaceutical company
CUSIP: 375558103
Healthcare
US
6 holders
Ownership
Activity
Fundamentals
2015 Q3
42 of 52 quarters
Total Value
$641.22M
Total Shares
6.53M
Net Share Change
+1.74M
Activity
3 buying
1 selling
Investor
Value
Shares
Weight
Change
Egerton Capital
$548.96M
5.59M
6.2%
ADD
+1.59M
(+39.8%)
Egerton Capital
$548.96M
5.59M shares
ADD
+1.59M
(+39.8%)
Miller Value Partners
$52.94M
539.1K
1.7%
Unchanged
Miller Value Partners
$52.94M
539.1K shares
Unchanged
Bridgewater Associates LP
$21.81M
222.1K
0.3%
ADD
+140.4K
(+171.8%)
Bridgewater Associates LP
$21.81M
222.1K shares
ADD
+140.4K
(+171.8%)
Matrix Asset Advisors
$16.88M
171.9K
2.4%
ADD
+7.3K
(+4.5%)
Matrix Asset Advisors
$16.88M
171.9K shares
ADD
+7.3K
(+4.5%)
Jensen Investment Management
$408.0K
4.2K
0.0%
TRIM
-480
(-10.3%)
Jensen Investment Management
$408.0K
4.2K shares
TRIM
-480
(-10.3%)
Maverick Capital
$230.0K
2.3K
0.0%
Unchanged
Maverick Capital
$230.0K
2.3K shares
Unchanged
GILD — Gilead Sciences, Inc. - FilingSpy